Daiwa Securities Group Inc. Hutchmed (China) LTD Transaction History
Daiwa Securities Group Inc.
- $21.6 Billion
- Q3 2024
A detailed history of Daiwa Securities Group Inc. transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 85 shares of HCM stock, worth $1,212. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85
Previous 85
-0.0%
Holding current value
$1,212
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding HCM
# of Institutions
65Shares Held
6.88MCall Options Held
6.2KPut Options Held
1.1K-
Schroder Investment Management Group London, X02.92MShares$41.7 Million0.06% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M1.32MShares$18.9 Million0.04% of portfolio
-
State Street Corp Boston, MA350KShares$4.99 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$4.5 Million0.17% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny310KShares$4.42 Million0.0% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.47B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...